Article Sidebar
Published:
Aug 19, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
FAM172A inhibits breast cancer cell growth and metastasis by upregulating Notch 3
Abstract
Purpose: To investigate the role of family with sequence similarity 172 member A (FAM172A) in breast cancer.
Methods: FAM172A expression was evaluated by western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR). Colony formation and CCK-8 assays were used to assess cell proliferation, while cell migration and invasion were evaluated by Transwell assay.
Results: FAM172A expression was reduced in breast cancer cells and tissues when compared to controls (p < 0.001). Overexpression of FAM172A repressed proliferation of breast cancer cells (p < 0.001) and suppressed cell migration and invasion (p < 0.001). Overexpression of FAM172A increased Notch 3 expression in breast cancer cells. Knockdown of Notch 3 attenuated the FAM172A overexpression-induced decrease in breast cancer cell proliferation. Silencing of Notch 3 reversed the FAM172A (p < 0.001).
Conclusion: FAM172A represses breast cancer cell growth and metastasis via upregulation of Notch 3; thus, FAM172A and Notch 3 are potential targets for breast cancer therapy.
Keywords:
